Viral load and cytokine response profile does not support antibody-dependent enhancement in Dengue-Primed Zika Virus-infected patients

Ana Carolina Bernardes Terzian, Alessandra Soares Schanoski, Mânlio Tasso De Oliveira Mota, Rafael Alves Da Silva, Cássia Fernanda Estofolete, Tatiana Elias Colombo, Paula Rahal, Kathryn A. Hanley, Nikos Vasilakis, Jorge Kalil, Maurício Lacerda Nogueira

Research output: Contribution to journalArticle

36 Citations (Scopus)

Abstract

Background: The pathogenesis of severe dengue disease involves immune components as biomarkers. The mechanism by which some dengue virus (DENV)-infected individuals progress to severe disease is poorly understood. Most studies on the pathogenesis of severe dengue disease focus on the process of antibody-dependent enhancement (ADE) as a primary risk factor. With the circulation of Zika virus (ZIKV) in DENV-endemic areas, many people infected by ZIKV were likely exposed to DENV. The influence of such exposure on Zika disease outcomes remains unknown. Methods: We investigated whether patients previously exposed to DENV exhibited higher viremia when exposed to a subsequent, heterologous dengue or Zika infection than those patients not previously exposed to dengue. We measured viral loads and cytokine profile during patients' acute infections. Results: Neither dengue nor Zika viremia was higher in patients with prior DENV infection, although the power to detect such a difference was only adequate in the ZIKV analysis. Of the 10 cytokines measured, only 1 significant difference was detected: Levels of interleukin 1β (IL-1β) were lower in dengue-infected patients who had experienced a previous dengue infection than patients infected with dengue for the first time. However, power to detect differences between groups was low. In Zika-infected patients, levels of IL-1β showed a significant, positive correlation with viral load. Conclusions. No signs of ADE were observed in vivo in patients with acute ZIKV infection who had prior exposure to DENV.

Original languageEnglish (US)
Pages (from-to)1260-1265
Number of pages6
JournalClinical Infectious Diseases
Volume65
Issue number8
DOIs
StatePublished - Oct 1 2017

Fingerprint

Antibody-Dependent Enhancement
Dengue
Viral Load
Dengue Virus
Cytokines
Severe Dengue
Viremia
Interleukin-1
Infection
Zika Virus
Immune System Diseases
Virus Diseases
Biomarkers

Keywords

  • ADE
  • Cytokines
  • DENV
  • ZIKV

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Cite this

Terzian, A. C. B., Schanoski, A. S., De Oliveira Mota, M. T., Da Silva, R. A., Estofolete, C. F., Colombo, T. E., ... Nogueira, M. L. (2017). Viral load and cytokine response profile does not support antibody-dependent enhancement in Dengue-Primed Zika Virus-infected patients. Clinical Infectious Diseases, 65(8), 1260-1265. https://doi.org/10.1093/cid/cix558

Viral load and cytokine response profile does not support antibody-dependent enhancement in Dengue-Primed Zika Virus-infected patients. / Terzian, Ana Carolina Bernardes; Schanoski, Alessandra Soares; De Oliveira Mota, Mânlio Tasso; Da Silva, Rafael Alves; Estofolete, Cássia Fernanda; Colombo, Tatiana Elias; Rahal, Paula; Hanley, Kathryn A.; Vasilakis, Nikos; Kalil, Jorge; Nogueira, Maurício Lacerda.

In: Clinical Infectious Diseases, Vol. 65, No. 8, 01.10.2017, p. 1260-1265.

Research output: Contribution to journalArticle

Terzian, ACB, Schanoski, AS, De Oliveira Mota, MT, Da Silva, RA, Estofolete, CF, Colombo, TE, Rahal, P, Hanley, KA, Vasilakis, N, Kalil, J & Nogueira, ML 2017, 'Viral load and cytokine response profile does not support antibody-dependent enhancement in Dengue-Primed Zika Virus-infected patients', Clinical Infectious Diseases, vol. 65, no. 8, pp. 1260-1265. https://doi.org/10.1093/cid/cix558
Terzian, Ana Carolina Bernardes ; Schanoski, Alessandra Soares ; De Oliveira Mota, Mânlio Tasso ; Da Silva, Rafael Alves ; Estofolete, Cássia Fernanda ; Colombo, Tatiana Elias ; Rahal, Paula ; Hanley, Kathryn A. ; Vasilakis, Nikos ; Kalil, Jorge ; Nogueira, Maurício Lacerda. / Viral load and cytokine response profile does not support antibody-dependent enhancement in Dengue-Primed Zika Virus-infected patients. In: Clinical Infectious Diseases. 2017 ; Vol. 65, No. 8. pp. 1260-1265.
@article{95628273d5fd4d41b8d3eb591ed85d86,
title = "Viral load and cytokine response profile does not support antibody-dependent enhancement in Dengue-Primed Zika Virus-infected patients",
abstract = "Background: The pathogenesis of severe dengue disease involves immune components as biomarkers. The mechanism by which some dengue virus (DENV)-infected individuals progress to severe disease is poorly understood. Most studies on the pathogenesis of severe dengue disease focus on the process of antibody-dependent enhancement (ADE) as a primary risk factor. With the circulation of Zika virus (ZIKV) in DENV-endemic areas, many people infected by ZIKV were likely exposed to DENV. The influence of such exposure on Zika disease outcomes remains unknown. Methods: We investigated whether patients previously exposed to DENV exhibited higher viremia when exposed to a subsequent, heterologous dengue or Zika infection than those patients not previously exposed to dengue. We measured viral loads and cytokine profile during patients' acute infections. Results: Neither dengue nor Zika viremia was higher in patients with prior DENV infection, although the power to detect such a difference was only adequate in the ZIKV analysis. Of the 10 cytokines measured, only 1 significant difference was detected: Levels of interleukin 1β (IL-1β) were lower in dengue-infected patients who had experienced a previous dengue infection than patients infected with dengue for the first time. However, power to detect differences between groups was low. In Zika-infected patients, levels of IL-1β showed a significant, positive correlation with viral load. Conclusions. No signs of ADE were observed in vivo in patients with acute ZIKV infection who had prior exposure to DENV.",
keywords = "ADE, Cytokines, DENV, ZIKV",
author = "Terzian, {Ana Carolina Bernardes} and Schanoski, {Alessandra Soares} and {De Oliveira Mota}, {M{\^a}nlio Tasso} and {Da Silva}, {Rafael Alves} and Estofolete, {C{\'a}ssia Fernanda} and Colombo, {Tatiana Elias} and Paula Rahal and Hanley, {Kathryn A.} and Nikos Vasilakis and Jorge Kalil and Nogueira, {Maur{\'i}cio Lacerda}",
year = "2017",
month = "10",
day = "1",
doi = "10.1093/cid/cix558",
language = "English (US)",
volume = "65",
pages = "1260--1265",
journal = "Clinical Infectious Diseases",
issn = "1058-4838",
publisher = "Oxford University Press",
number = "8",

}

TY - JOUR

T1 - Viral load and cytokine response profile does not support antibody-dependent enhancement in Dengue-Primed Zika Virus-infected patients

AU - Terzian, Ana Carolina Bernardes

AU - Schanoski, Alessandra Soares

AU - De Oliveira Mota, Mânlio Tasso

AU - Da Silva, Rafael Alves

AU - Estofolete, Cássia Fernanda

AU - Colombo, Tatiana Elias

AU - Rahal, Paula

AU - Hanley, Kathryn A.

AU - Vasilakis, Nikos

AU - Kalil, Jorge

AU - Nogueira, Maurício Lacerda

PY - 2017/10/1

Y1 - 2017/10/1

N2 - Background: The pathogenesis of severe dengue disease involves immune components as biomarkers. The mechanism by which some dengue virus (DENV)-infected individuals progress to severe disease is poorly understood. Most studies on the pathogenesis of severe dengue disease focus on the process of antibody-dependent enhancement (ADE) as a primary risk factor. With the circulation of Zika virus (ZIKV) in DENV-endemic areas, many people infected by ZIKV were likely exposed to DENV. The influence of such exposure on Zika disease outcomes remains unknown. Methods: We investigated whether patients previously exposed to DENV exhibited higher viremia when exposed to a subsequent, heterologous dengue or Zika infection than those patients not previously exposed to dengue. We measured viral loads and cytokine profile during patients' acute infections. Results: Neither dengue nor Zika viremia was higher in patients with prior DENV infection, although the power to detect such a difference was only adequate in the ZIKV analysis. Of the 10 cytokines measured, only 1 significant difference was detected: Levels of interleukin 1β (IL-1β) were lower in dengue-infected patients who had experienced a previous dengue infection than patients infected with dengue for the first time. However, power to detect differences between groups was low. In Zika-infected patients, levels of IL-1β showed a significant, positive correlation with viral load. Conclusions. No signs of ADE were observed in vivo in patients with acute ZIKV infection who had prior exposure to DENV.

AB - Background: The pathogenesis of severe dengue disease involves immune components as biomarkers. The mechanism by which some dengue virus (DENV)-infected individuals progress to severe disease is poorly understood. Most studies on the pathogenesis of severe dengue disease focus on the process of antibody-dependent enhancement (ADE) as a primary risk factor. With the circulation of Zika virus (ZIKV) in DENV-endemic areas, many people infected by ZIKV were likely exposed to DENV. The influence of such exposure on Zika disease outcomes remains unknown. Methods: We investigated whether patients previously exposed to DENV exhibited higher viremia when exposed to a subsequent, heterologous dengue or Zika infection than those patients not previously exposed to dengue. We measured viral loads and cytokine profile during patients' acute infections. Results: Neither dengue nor Zika viremia was higher in patients with prior DENV infection, although the power to detect such a difference was only adequate in the ZIKV analysis. Of the 10 cytokines measured, only 1 significant difference was detected: Levels of interleukin 1β (IL-1β) were lower in dengue-infected patients who had experienced a previous dengue infection than patients infected with dengue for the first time. However, power to detect differences between groups was low. In Zika-infected patients, levels of IL-1β showed a significant, positive correlation with viral load. Conclusions. No signs of ADE were observed in vivo in patients with acute ZIKV infection who had prior exposure to DENV.

KW - ADE

KW - Cytokines

KW - DENV

KW - ZIKV

UR - http://www.scopus.com/inward/record.url?scp=85032808035&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032808035&partnerID=8YFLogxK

U2 - 10.1093/cid/cix558

DO - 10.1093/cid/cix558

M3 - Article

VL - 65

SP - 1260

EP - 1265

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

SN - 1058-4838

IS - 8

ER -